Who Paid My Doc
M17-327
ClinicalTrials.gov NCT03639194
Research payments
$1,635,004
Through program year 2020, $1,635,004 in research payments was reported against M17-327, across 169 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT03639194
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $969,554 | 118 |
| 2019 | Research | $665,450 | 51 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Todd Bauer Nashville, TN Named on 46 payments
- Francisco Vizcarrondo Birmingham, AL Named on 30 payments
- Anthony Tolcher San Antonio, TX Named on 22 payments
- Muhammad Furqan Iowa City, IA Named on 17 payments
- Daniel Morgensztern Saint Louis, MO Named on 17 payments
- Eric Schaefer Fayetteville, AR Named on 14 payments
- Anna Farago Boston, MA Named on 7 payments
- Wallace Akerley Salt Lake City, UT Named on 6 payments
- Shirish Gadgeel Detroit, MI Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.